The Convergence of CRISPR and Human Stem Cells

Sdílet
Vložit
  • čas přidán 19. 01. 2021
  • Gladstone President Deepak Srivastava moderated a conversation with Jennifer Doudna and Shinya Yamanaka to discuss the potential impact of CRISPR and iPS cells over the coming decade and hear from the two world-class scientists about how they plan to shape the enormous opportunities that lie ahead.
    Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for his discovery of induced pluripotent stem cells (iPS cells). And last year, Doudna received the Nobel Prize in Chemistry for her co-discovery of the CRISPR-Cas9 gene-editing technology. Arguably the two most impactful advances of this century, the discoveries by these Gladstone investigators are now accelerating our understanding and treatment of human disease at an unprecedented pace.
  • Věda a technologie

Komentáře • 22

  • @kevinjimoh2921
    @kevinjimoh2921 Před 2 lety +3

    Crazy. Crazy crazy crazy.
    Thank you guys for having this talk and making it accessible to me. It means more than you know

  • @tiantina6159
    @tiantina6159 Před 2 lety +3

    As a biochemical graduate now working in a completely different industry, the information shared in this conversation is still inspiring. It kinda made me want to go back into the "boring" research lab routine and reset my entire career life!

    • @SirRULE1
      @SirRULE1 Před 2 lety

      Why do you describe it a BORING research lab

  • @lilysunshine3447
    @lilysunshine3447 Před 3 lety +5

    Humans working to their full potential.

  • @eternalambition
    @eternalambition Před 2 lety

    Thank you So much for this talk...the meeting of 3 great individuals in one talk...miraculous!!!

  • @ammaarmoulana5534
    @ammaarmoulana5534 Před 3 lety +5

    Loved this talk. :)

  • @lifeeasier3462
    @lifeeasier3462 Před rokem

    Such a privilege to have this available. What are the current successful applications of both technologies?

  • @kamislava2795
    @kamislava2795 Před 2 lety

    Большое СПАСИЙБО

  • @melissabracken5172
    @melissabracken5172 Před rokem +1

    Stem cells expanded from umbilical cords that are normally thrown away shouldn't pose an issue.
    I feel like the pharmaceutical industry is the reason we are being held back from therapies that are being practiced on a regular basis in other countries.
    I just got back from receiving stem cell therapy through an IV on three separate days and had two grams of placental implants injected into my abdomen. All these treatments, including the over 150,000,000 stem cells, cost less than $3,000 US dollars in Guadalajara! I also received stem cells expanded from the pulp of children's teeth, peptides, and exosomes, as well. These fresh stem cells were nearly 100% viable. They were not cryogenically frozen beforehand and thawed.
    Why isn't this the norm in the US? Why does the pharmaceutical industry have so much power over here?

  • @directioner2870
    @directioner2870 Před 3 lety +2

    What about autoimmune diseases ???

    • @zillypru1159
      @zillypru1159 Před 3 lety

      Do it to the glory of God forget these commercial outfits .. i

    • @directioner2870
      @directioner2870 Před 3 lety

      @@zillypru1159 I don't care about CRISPR anymore I'm now focusing on HSCT because it has chances of a cure 🌹🌹🌹🌹💜

    • @YadinZedek777
      @YadinZedek777 Před 2 lety +1

      @@directioner2870 if what they are saying works you might not need to do HSCT

    • @finakhan1038
      @finakhan1038 Před rokem

      See my post.

    • @finakhan1038
      @finakhan1038 Před rokem

      @@directioner2870 see my post.

  • @metipallearuna223
    @metipallearuna223 Před 9 měsíci

    Like creating some mis-sense that nobody would've seen it in an Ant moving on the pair of false walking legs without any lab facilities like crispr cas9 editing.